International Journal of Pharmaceutical Process Chemistry
https://matjournals.net/pharmacy/index.php/IJPPC
<p>IJPPC provide its readers with up-to-date information relevant to pharmaceutical Process Chemistry. The journal policy is to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field. The focus and scope of this Journal including Medicinal Chemistry, Chemical Development, Pharmaceutical Engineering, Pharmaceutical Industry, Pharmaceutical Drugs, Drug Design, pharmacokinetics, molecular modelling, Chemical Biology, Biological agents.</p>en-USInternational Journal of Pharmaceutical Process ChemistryA Comprehensive Review on pH Meters: Principles, Calibration, Applications, and Challenges
https://matjournals.net/pharmacy/index.php/IJPPC/article/view/236
<p><em>An indispensable electrical tool for determining the PH of solutions and calculating the concentration of hydrogen ion is a PH meter. A solutions acidity or alkalinity can be determined by using the PH scale, which goes from 0 to 14. Values below 7 indicate acidity, values above 7 indicate basicity, and 7 indicate neutrality. PH meters are widely used in biological, chemical, and environmental research because they provide precise PH readings that help with process management and reaction mechanism comprehension. In order to ensure linearity and dependability within this range, modern PH meter are frequently calibrated using standard buffer solution preserves the accuracy and validity of data by compensating for possible drift brought on by aging electrodes or meter composition. Digital PH meter, in contrast to conventional techniques, provide improved precision of up to 0.01% and provide exact numerical results. In order to provide consistent hydrogen ion concentration hydrogen ion concentration readings, a magnetic stirrer was used in this work to homogenize solutions during PH measurement. In order to handle changes in electrode characteristics over tine and guarantee accurate and repeatable PH reading for a variety of applications, routine calibration and validation using known buffer solution are essential.</em></p>Akash Raosaheb MisalSupekar Ayodhya BalasahebTambe Supriya AnnasahebHemant Hiraman Gangurde
Copyright (c) 2025 International Journal of Pharmaceutical Process Chemistry
2025-10-102025-10-100108A New Approach to Naso Pulmonary Drug Delivery System
https://matjournals.net/pharmacy/index.php/IJPPC/article/view/256
<p><em>Drugs can be administered by nasal administration, which involves inhaling them through the nose.</em><em> Naso-pulmonary medication delivery is a cutting-edge and exciting method for administering therapeutic drugs locally as well as systemically. </em><em>Among the many advantages of the nasal route are its large surface area, strong vascularization. </em><em>It ensures rapid onset and avoids the drug’s early metabolism in the liver. It allows effective delivery of drugs, proteins, and peptides that cannot remain stable in the digestive system. </em><em>Pulmonary delivery provides individualized treatment for respiratory conditions such as asthma, COPD, and pulmonary infections by increasing medication efficacy and lowering systemic side effects. Numerous factors, such as formulation properties, pH, mucociliary clearance, lipophilicity, and molecular size, affect drug absorption through the nasal and pulmonary routes. The various dosage forms that allow for flexible and effective administration include nasal drops, sprays, gels, and powders</em><em>. </em><em>Thanks to advancements in formulation science and nanotechnology, naso-pulmonary medication delivery is a practical, non-invasive, and efficient way to treat respiratory and systemic disorders.</em></p>Kuldeep YadavKaramjit KaurAbhinav KishorRavina Rani
Copyright (c) 2025 International Journal of Pharmaceutical Process Chemistry
2025-12-042025-12-04917Catalyst: A Detailed Study & Applications in Drug Design
https://matjournals.net/pharmacy/index.php/IJPPC/article/view/265
<p><em>Catalysts play a pivotal role in accelerating chemical reactions without undergoing permanent changes themselves, and their application in drug design has transformed modern pharmaceutical development. This study explores the fundamental principles of catalysis, including types such as acid-base, enzymatic, and organometallic catalysts, and their significance in drug synthesis, green chemistry, and targeted delivery. Particular focus is given to how biocatalyst and transmission-Metal complexes drive stereoselective transformations, improving overall reaction efficiency while minimising environmental impact. Through selected case studies, including the synthesis of Ibrutinib and other kinase inhibitors, the project highlights how catalyst-based methodologies lead to higher yield, improved selectivity, and reduced reaction times. The investigation also delves into computational approaches to catalyst optimization in drug discovery workflows. Overall, this study underscores the growing importance of catalytic systems in sustainable pharmaceutical innovation and rational drug design. </em></p>Sirisha TPrasanna DaasiM. RozyV. SailiV. Sneha Lakshmi
Copyright (c) 2025 International Journal of Pharmaceutical Process Chemistry
2025-12-112025-12-111830Nanotechnology in Drug Delivery Systems: Advances, Challenges, and Future Perspectives
https://matjournals.net/pharmacy/index.php/IJPPC/article/view/287
<p><span style="font-style: normal !msorm;"><em>Modern drug delivery has undergone a revolution thanks to nanotechnology, which addresses the drawbacks of traditional treatments. Nanomedicines increase drug solubility, improve absorption, and allow targeted distribution to particular tissues or cells by creating nanoparticles with exact sizes, surface characteristics, and functional changes. Nanotechnology enables unprecedented precision in medicine. By designing nanoparticles that can cross biological barriers, such as the blood-brain barrier, drugs can reach previously inaccessible sites, thereby maximizing therapeutic outcomes. These nanoscale carriers can respond to physiological triggers like pH, temperature, or specific enzymes to release their payloads only when and where needed. Surface engineering with ligands, antibodies, or polymers further enhances specificity, ensuring that diseased cells are targeted while healthy tissues remain unharmed. This precision not only reduces systemic toxicity and side effects but also allows combination therapies within a single carrier, promoting synergistic effects and improving patient adherence. Beyond therapy, nanomedicine offers diagnostic capabilities, enabling simultaneous detection and treatment of diseases, paving the way for true “theranostic” approaches. Large-scale production, thorough assessment of long-term safety, toxicity profile, and adherence to strict regulatory standards are some of the major obstacles the area must overcome despite its potential. Clinical translation is being accelerated by ongoing research, better testing techniques, and the creation of intelligent nanocarriers that can integrate therapeutic and diagnostic functionalities or react to physiological signals. In the end, the successful application of nanotechnology in healthcare will rely on ongoing cooperation between researchers, medical professionals, and regulatory bodies to guarantee accessible, safe, and efficient treatments. </em></span></p>Haroon Rashid DarHarmanpreet KaurGurisha GargAyush Gandhi
Copyright (c) 2025 International Journal of Pharmaceutical Process Chemistry
2025-12-292025-12-293144The Rise of Bioinspired Pharmaceuticals: Learning from Nature to Heal the Future
https://matjournals.net/pharmacy/index.php/IJPPC/article/view/288
<p><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>Backgrou</em></strong></span><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>nd:</em></strong></span><span style="font-style: normal !msorm;"><em> Bioinspired pharmaceutical </em></span><span style="font-style: normal !msorm;"><em>therapeutics whose design and function are informed by natural </em></span><span style="font-style: normal !msorm;"><em>mole</em></span><span style="font-style: normal !msorm;"><em>cules and biological mechanisms </em></span><span style="font-style: normal !msorm;"><em>are emerging as a transformative approach to drug discovery.</em></span></p> <p><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>Objective:</em></strong></span><span style="font-style: normal !msorm;"><em> This original research-style paper evaluates the principles, applications, and translational potential of bioinspired pharmaceuticals, using a synt</em></span><span style="font-style: normal !msorm;"><em>hesized dataset to demonstrate comparative performance against conventional synthetic analogues.</em></span></p> <p><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>Methods:</em></strong></span><span style="font-style: normal !msorm;"><em> We conducted a structured literature synthesis and constructed a simulated dataset (n = 152 compounds) comprising natural-product-derived leads and b</em></span><span style="font-style: normal !msorm;"><em>ioinspired analogues. Statistical comparisons of in vitro potency, selectivity index, and predicted oral bioavailability were performed using t-tests and multivariate regression.</em></span></p> <p><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>Results:</em></strong></span><span style="font-style: normal !msorm;"><em> Bioinspired analogues showed a mean improvement in potency (IC50 re</em></span><span style="font-style: normal !msorm;"><em>duction) of 28.6% (95% CI 21.4–35.8; p<0.001) and an increased selectivity index by 22.1% (95% CI 15.2–29.0; p=0.002) compared with conventional synthetic scaffolds. Predicted oral bioavailability improved modestly (mean increase 9.4%, p=0.04).</em></span></p> <p><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>Conclusion</em></strong></span><span style="font-weight: normal !msorm; font-style: normal !msorm;"><strong><em>:</em></strong></span><span style="font-style: normal !msorm;"><em> The simulated analysis supports the proposition that bioinspired design can yield therapeutics with favorable pharmacological profiles. Continued integration of computational modeling, synthetic biology, and scalable production platforms is required to t</em></span><span style="font-style: normal !msorm;"><em>ranslate these gains into clinical impact.</em></span></p>Rehan HaiderZameer AhmedSambreen Zameer
Copyright (c) 2025 International Journal of Pharmaceutical Process Chemistry
2025-12-292025-12-29455110.46610/IJPPC.2025.v01i02.005